Novo Nordisk Obesity Corporate Narrative
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes and obesity care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions such as haemophilia and growth disorders.
A heritage of driving change
Going beyond medicine, we also recognise that to improve care for people living with obesity, change needs to happen across society – from prevention and defeating stigma to enacting the right policies and using the right treatments when needed.